What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
|Nov. 25||Weekly Gain||My Watchlist|
Global Education was last week's biggest winner, more than doubling after agreeing to be acquired by British publisher Pearson
Pharmasset also spiked on buyout news. Early success on an oral treatment for hepatitis C was enough to woo a meaty acquisition offer from Gilead Sciences
Pozen gained some serious ground after selling the U.S. royalty rights for its migraine drug to Canada's national pension fund in a $75 million deal.
InterOil is certainly not boring. The volatile Australian oil and natural gas explorer with interest in Papua New Guinea rose 10% on Monday and another 10% on Tuesday before tumbling 14% on Wednesday. It inched 6% higher on Friday after the break. Outside of inking a liquefied natural gas deal on Friday, there wasn't a lot of material news to move the stock. InterOil swings higher and lower, simply because it can.
Finally, we have Mobile TeleSystems certainly not phoning it in. The Russian telco provider saw its shares post a modest double-digit percentage gain on the week after delivering better-than-expected quarterly results.
It was a great week for these five stocks. Now let's see if they're up for an encore.
Which of these five stocks do you think will continue to move higher? Share your thoughts in the comments box below.
Motley Fool newsletter services have recommended buying shares of Gilead Sciences. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.